YmAbs Therapeutics (YMAB)
(Delayed Data from NSDQ)
$15.13 USD
+0.13 (0.87%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $15.14 +0.01 (0.07%) 7:58 PM ET
1-Strong Buy of 5 1
F Value D Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/13/2024
Time: -- |
3/2024 | $-0.12 | 0.00% |
Earnings Summary
For their last quarter, YmAbs Therapeutics (YMAB) reported earnings of -$0.02 per share, beating the Zacks Consensus Estimate of $-0.19 per share. This reflects a positive earnings surprise of 89.47%. Look out for YMAB's next earnings release expected on May 13, 2024. For the next earning release, we expect the company to report earnings of -$0.12 per share, reflecting a year-over-year increase of 20%.
Earnings History
Price & Consensus
Zacks News for YMAB
New Strong Buy Stocks for April 17th
YMAB: What are Zacks experts saying now?
Zacks Private Portfolio Services